Home/Filings/4/0001209191-17-038881
4//SEC Filing

ANTARES PHARMA, INC. 4

Accession 0001209191-17-038881

CIK 0001016169operating

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 4:24 PM ET

Size

5.7 KB

Accession

0001209191-17-038881

Insider Transaction Report

Form 4
Period: 2017-06-07
Transactions
  • Award

    Stock Option (right to buy)

    2017-06-07+80,31880,318 total
    Exercise: $2.66Exp: 2027-06-07Common Stock (80,318 underlying)
Footnotes (2)
  • [F1]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
  • [F2]The options vest in equal quarterly installments over one year from grant date.

Issuer

ANTARES PHARMA, INC.

CIK 0001016169

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001016169

Filing Metadata

Form type
4
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:24 PM ET
Size
5.7 KB